Ying Cheng
- Ophthalmology top 5%
- Glaucoma and retinal disorders 10
- Retinal Diseases and Treatments 9
- Cancer Research top 10%
- Pharmaceutical Science top 10%
- Hepatology top 10%
-
- Lung Cancer Research Studies 9
- Colorectal Cancer Treatments and Studies 6
- HER2/EGFR in Cancer Research 4
- Pancreatic and Hepatic Oncology Research 3
- Peptidase Inhibition and Analysis 3
-
- Lung Cancer Treatments and Mutations 7
- Journals
- Journal of Clinical Oncology (10 papers)Journal of Thoracic Oncology (3 papers)Annals of Oncology (3 papers)
- Partner nations
- ChinaUnited StatesJapan
In The Last Decade
Ying Cheng
41 papers receiving 600 citations
Peers
Comparison fields: 5 of 73
- Ophthalmology 133
- Cancer Research 174
- Pharmaceutical Science 54
- Hepatology 66
- Oncology 117
Countries citing papers authored by Ying Cheng
This map shows the geographic impact of Ying Cheng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ying Cheng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ying Cheng more than expected).
Fields of papers citing papers by Ying Cheng
This network shows the impact of papers produced by Ying Cheng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ying Cheng. The network helps show where Ying Cheng may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Ying Cheng, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 1 | |
| 3 | 2025 | 0 | |
| 4 | 2024 | 2 | |
| 5 | 2024 | 0 | |
| 6 | 2024 | 1 | |
| 7 | 2024 | 0 | |
| 8 | 2024 | 0 | |
| 9 | 2024 | 1 | |
| 10 | 2024 | 3 | |
| 11 | 2023 | 3 | |
| 12 | 2023 | 3 | |
| 13 | 2023 | 6 | |
| 14 | 2022 | 2 | |
| 15 | 2022 | 14 | |
| 16 | 2021 | 1 | |
| 17 | 2019 | 7 | |
| 18 | 2017 | 1 | |
| 19 | 2017 | 19 | |
| 20 | 2017 | 13 |
About Ying Cheng
Ying Cheng is a scholar working on Ophthalmology, Oncology, Pulmonary and Respiratory Medicine, Radiology, Nuclear Medicine and Imaging and Toxicology, having authored 48 papers that have together received 605 indexed citations. Recurring topics across this work include Glaucoma and retinal disorders (10 papers), Retinal Diseases and Treatments (9 papers), Lung Cancer Research Studies (9 papers), Lung Cancer Treatments and Mutations (7 papers), Colorectal Cancer Treatments and Studies (6 papers), HER2/EGFR in Cancer Research (4 papers), Pancreatic and Hepatic Oncology Research (3 papers) and Peptidase Inhibition and Analysis (3 papers). The work is most often cited by research in Ophthalmology (133 citations), Cancer Research (174 citations), Pharmaceutical Science (54 citations), Hepatology (66 citations) and Oncology (117 citations). Ying Cheng has collaborated with scholars based in China, United States and Japan. Frequent co-authors include Yi Qu, Yi Qu, Xingzhen Zhang, Jin Li, Ningli Wang, Yi Qu, Lining Miao, Manyu Luo, Hongge Wang and Yanqin Sun. Their work appears in journals such as Journal of Clinical Oncology, Journal of Thoracic Oncology, Annals of Oncology, Experimental Eye Research and International Journal of Molecular Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.